PRKAA1 and metabolic dysfunction-associated steatotic liver disease: In non-alcoholic fatty liver disease (NAFLD), AMPK activation induces ubiquitin-mediated degradation of PLIN2, a protein coating lipid droplets, thereby enhancing the fusion of lipid droplets with autophagosomes and accelerating lipid hydrolysis (lipophagy).